Tryptophan produced by Showa Denko and epidemic eosinophilia-myalgia syndrome

Journal of Rheumatology

Volumn 23, Issue SUPPL. 46, 1996, Pages 81-88

  Kilbourne, Edwin M ^a,b   Philen, Rossanne M ^a,c   Kamb, Mary L ^a,d   Falk, Henry ^a,c  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CDC   (United States)

^c NATIONAL CENTER FOR ENVIRONMENTAL HEALTH   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

diagnosis; eosinophilia myalgia syndrome; epidemiology; L tryptophan

Indexed keywords

TRYPTOPHAN;

CONFERENCE PAPER; CONTROLLED STUDY; EOSINOPHILIA MYALGIA SYNDROME; HUMAN; PRIORITY JOURNAL; CHEMICALLY INDUCED DISORDER; DRUG INDUSTRY; NOTE;

DRUG INDUSTRY; EOSINOPHILIA-MYALGIA SYNDROME; HUMANS; TRYPTOPHAN;

EID: 0030255853     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Shapiro S: Epidemiologic studies of the association of L-tryptophan with the eosinophilia-myalgia syndrome: A critique. J Rheumatol 1996;(suppl 46)23:44-59.
2. Horwitz RI, Daniels SR: Bias or biology: Evaluating the epidemiologic studies of L-tryptophan and the eosinophilia-myalgia syndrome. J Rheumatol 1996;(suppl 46)23:60-72.
3. Eidson M, Philen RM, Sewell CM, Voorhees R, Kilbourne EM: L-tryptophan and eosinophilia-myalgia syndrome in New Mexico. Lancet 1990;335:645-8.
4. Eosinophilia-myalgia syndrome and L-tryptophan-containing products - New Mexico, Minnesota, Oregon, and New York, 1989. MMWR Morb Mortal Wkly Rep 1989;38:785-8.
5. Swygert LA, Maes EF, Sewell LE, Miller L, Falk H, Kilbourne EM: Eosinophilia-myalgia syndrome. Results of national surveillance. JAMA 1990;264:1698-703.
6. Belongia EA, Hedberg CW, Gleich GJ, et al: An investigation of the cause of the eosinophilia-myalgia syndrome associated with tryptophan use. N Engl J Med 1990;323:357-65.
7. Slutsker L, Hoesly FC, Miller L, Williams LP, Watson JC, Fleming DW: Eosinophilia-myalgia syndrome associated with exposure to tryptophan from a single manufacturer. JAMA 1990;264:213-7.
8. Back EE, Henning KJ, Kallenbach LR, Brix KA, Gunn RA, Melius JM: Risk factors for developing eosinophilia-myalgia syndrome among L-tryptophan users in New York. J Rheumatol 1993;20:666-72.
9. Kamb ML, Murphy JJ, Jones JL, et al: Eosinophilia-myalgia syndrome in L-tryptophan exposed patients in a South Carolina psychiatric practice. JAMA 1992;267:77-82.
10. Philen RM, Hill RH Jr, Flanders WD, et al: Tryptophan contaminants associated with eosinophilia-myalgia syndrome. The eosinophilia-myalgia studies of Oregon, New York and New Mexico. Am J Epidemiol 1993;138:154-9.
11. Kilbourne EM: Eosinophilia-myalgia syndrome: Coming to grips with a new illness. Epidemiol Rev 1992;14:16-36.
12. Breslow NE, Day NE: Statistical Methods in Cancer Research. Volume I. The Analysis of Case-Control Studies. Lyon: International Agency for Research on Cancer, 1980:84-90.
13. Hill AB: A Short Textbook of Medical Statistics. Chap. 24: Statistical evidence and inference. London: Hodder and Stoughton, 1977:285-96.
14. Rothman KJ: Modern Epidemiology. Boston: Little, Brown & Co., 1986:16-20.
15. Schlesselman JJ: Case-Control Studies. Design, Conduct, Analysis. New York: Oxford University Press, 1982:22-5.
16. Spitzer WO, Haggerty JL, Berkson L, et al: Analysis of Centers for Disease Control and Prevention criteria for the eosinophilia-myalgia syndrome in a geographically defined population. J Rheumatol 1996;(suppl 46)23:73-80.
17. Shapiro S: L-tryptophan and eosinophilia-myalgia syndrome (letter). Lancet 1994;343:1035-6.
18. Shapiro S: L-tryptophan and eosinophilia-myalgia syndrome (letter). Lancet 1994;344:817-8.
19. Eidson M, Philen RM, Sewell CM, Voorhees RE, Kilbourne EM: L-tryptophan and eosinophilia-myalgia syndrome (reply to letter). Lancet 1994;343:1036-7.
20. Kilbourne EM, Eidson M, Philen EM, Voorhees RE, Sewell CM: L-tryptophan and eosinophilia-myalgia syndrome (reply to letter). Lancet 1994;344:818-9.
21. Eosinophilia-myalgia syndrome - Canada. MMWR Morb Mortal Wkly Rep 1990;39:326-7.
22. Principles of Epidemiology, 2nd ed. Atlanta: Centers for Disease Control and Prevention, 1992:12-3,357-9.